SELF-TEST FOR GLUCOSE - ANVISA Registration 80770430014

Access comprehensive regulatory information for SELF-TEST FOR GLUCOSE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80770430014 and manufactured by M.I. TECH CO., LTD. The registration is held by DMAX - DISTRIBUIDORA DE MEDICAMENTOS E MATERIAL HOSPITALAR LTDA - EPP with validity until Jan 04, 2031.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including OK BIOTECH CO., LTD., ROCHE DIABETES CARE GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80770430014
2 Related Devices
Registration Details
ANVISA Registration Number: 80770430014
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

TIRAS RAPICHECK
Risk Class III

Registration Details

80770430014

25351491691202041

09390408000191

Company Information

M.I. TECH CO., LTD
South Korea
PT: CORÉIA DO SUL

Dates and Status

Jan 04, 2021

04/01/2031

09/18/2025 19:00:01

TIRAS RAPICHECK
Risk Class III

Registration Details

80770430014

25351491691202041

09390408000191

Dates and Status

Jan 04, 2021

04/01/2031

09/18/2025 19:00:01